The global transplant diagnostic market size is expected to Reach US$ 1,299.2 Mn by 2026 and is projected to expand at a cumulative annual growth rate (CAGR) of 6.6% from 2019 to 2026. The global market is expanding at a relatively higher growth rate owing to increasing bone marrow transplantation practices, high incidences of pediatric transplantation surgery, occurrence of kidney disorder among geriatric population, and increasing clinical evidence to establish clinical efficacy of molecular assay technique.
This report on the transplant diagnostic market analyzes the current and future scenario of the global market. Rising incidence of chronic diseases such as chronic kidney disease (CKD), end-stage renal disease, coronary artery disease, and acute & chronic hepatitis among all age groups, particularly the geriatric population, is increasing the usage of transplant diagnostic techniques owing to the rise in organ transplantation. Increase in success rates of transplantation and favorable reimbursement policies and frequent funding are the major drivers of the global transplant diagnostic market.
The transplant diagnostic market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on screening, technique, application, product & services, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises major player’s product portfolio-based on technology & application to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global transplant diagnostic market.
Based on application, the market has been segmented into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The application segments have been analyzed based on available cost-effectiveness and preference use of technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2019 to 2026, considering 2019 as the base year.
Based on technique, the transplant diagnostic market has been classified into molecular assay and non-molecular assay. In terms of screening, the transplant diagnostic market has been segregated into pre-transplant diagnostic and post-transplant diagnostic. The market segments have been extensively analyzed based on prevalence of the chronic diseases, available transplant treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2026, considering 2019 as the base year.
Based on end-user, the transplant diagnostic market has been split into hospital & transplant centers, research laboratories, and others. In terms of product & services, the transplant diagnostic market has been classified into reagents & consumables, instruments, and software & services based on the product & services. The market segments have been extensively analyzed based on prevalence of the diseases, awareness levels among people about organ donations, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2026, considering 2019 as the base year.
In terms of region, the global transplant diagnostic market has been segmented into five major regions and the key countries in the respective regions are: North America (U.S., Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2019 to 2026, considering 2019 as the base year. The research study also covers the competitive scenario in these regions.
The report also profiles major players in the global transplant diagnostic market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include EMS Electro Medical Systems S.A., BTL corporate, Dornier MedTech GmbH, and Zimmer MedizinSysteme GmbH., Siemens AG, Boston Scientific Corporation, NCELER MEDICAL LTD, and Guangzhou Longest Science & Technology Co.
Report Segmentation:
Global Transplant Diagnostic Market, by Screening, 2016?2026
Global Transplant Diagnostic Market, by Technique, 2016?2026
Global Transplant Diagnostic Market, by Application, 2016?2026
Global Transplant Diagnostic Market, by Product & Services, 2016?2026
Global Transplant Diagnostic Market, by End-user, 2016?2026
Global Transplant Diagnostic Market, by Region, 2016?2026
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Transplant Diagnostic Market
4. Market Overview
4.1. Introduction
4.1.1. Technique Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.3.4. Trends
4.4. Global Transplant Diagnostic Market Analysis and Forecast, 2019–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Market Outlook
4.6.Regulatory Scenarios
4.7. Number of Transplantations, by Region/Country
4.8. Key Success Factors of Top 3 Companies
5. Global Transplant Diagnostic Market Analysis and Forecast, by Technique
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Global Transplant Diagnostic Market Value Forecast, by Technique , 2019–2026
5.3.1. Molecular Assay
5.3.2. Non-Molecular Assay
5.4. Market Attractiveness, by Technique
6. Global Transplant Diagnostic Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
6.3.1. Solid Organ Transplantation
6.3.1.1. Kidney
6.3.1.2. Liver
6.3.1.3. Heart
6.3.1.4. Lungs
6.3.1.5. Pancreas
6.3.1.6. Small Bowel
6.3.2. Stem Cell Transplantation
6.4. Market Attractiveness, by Application
7. Global Transplant Diagnostic Market Analysis and Forecast, by Screening
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Transplant Diagnostic Market Value Forecast, by Screening, 2019–2026
7.3.1. Pre-Transplant Diagnostic
7.3.2. Post-Transplant Diagnostic
7.3.3. Instruments
7.4. Market Attractiveness, by Screening
8. Global Transplant Diagnostic Market Analysis and Forecast, by Product & Services
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
8.3.1. Reagents & Consumables
8.3.2. Instruments
8.3.3. Software & Services
8.4. Market Attractiveness, by Product & Services
9. Global Transplant Diagnostic Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Transplant Diagnostic Market Value Forecast, by End-user, 2019–2026
9.3.1. Hospital & Transplant Centers
9.3.2. Research Laboratories
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Transplant Diagnostic Market Analysis and Forecast, by Region
10.1.Key Findings
10.2. Global Transplant Diagnostic Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3.Market Attractiveness, by Country/Region
11. North America Transplant Diagnostic Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. North America Transplant Diagnostic Market Value Forecast, by Technique , 2019–2026
11.2.1. Molecular Assay
11.2.2. Non-Molecular Assay
11.3. North America Transplant Diagnostic Market Value Forecast, by Application, 2019–2026
11.3.1. Solid Organ Transplantation
11.3.1.1. Kidney
11.3.1.2. Liver
11.3.1.3. Heart
11.3.1.4. Lungs
11.3.1.5. Pancreas
11.3.1.6. Small Bowel
11.3.2. Stem Cell Transplantation
11.4. North America Transplant Diagnostic Market Value Forecast, by Screening, 2019–2026
11.4.1. Pre-Transplant Diagnostic
11.4.2. Post-Transplant Diagnostic
11.4.3. Instruments
11.5. North America Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
11.5.1. Reagents & Consumables
11.5.2. Instruments
11.5.3. Software & Services
11.6. North America Transplant Diagnostic Market Value Forecast, by End-user, 2019–2026
11.6.1. Hospital & Transplant Centers
11.6.2. Research Laboratories
11.6.3. Others
11.7. North America Transplant Diagnostic Market Value Forecast, by Country, 2019–2026
11.7.1. U.S.
11.7.2. Canada
11.8. North America Transplant Diagnostic Market Attractiveness Analysis
11.8.1. By Technique
11.8.2. By Application
11.8.3. By Screening
11.8.4. By Product & Services
11.8.5. By End-user
11.8.6. By Country
12. Europe Transplant Diagnostic Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Europe Transplant Diagnostic Market Value Forecast, by Technique , 2019–2026
12.2.1. Molecular Assay
12.2.2. Non-Molecular Assay
12.3. Europe Transplant Diagnostic Market Value Forecast, by Application, 2019–2026
12.3.1. Solid Organ Transplantation
12.3.1.1. Kidney
12.3.1.2. Liver
12.3.1.3. Heart
12.3.1.4. Lungs
12.3.1.5. Pancreas
12.3.1.6. Small Bowel
12.3.2. Stem Cell Transplantation
12.4. Europe Transplant Diagnostic Market Value Forecast, by Screening, 2019–2026
12.4.1. Pre-Transplant Diagnostic
12.4.2. Post-Transplant Diagnostic
12.4.3. Instruments
12.5. Europe Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
12.5.1. Reagents & Consumables
12.5.2. Instruments
12.5.3. Software & Services
12.6. Europe Transplant Diagnostic Market Value Forecast, by End-user, 2019–2026
12.6.1. Hospital & Transplant Centers
12.6.2. Research Laboratories
12.6.3. Others
12.7. Europe Transplant Diagnostic Market Value Forecast, by Country, 2019–2026
12.7.1. Germany
12.7.2. U.K.
12.7.3. France
12.7.4. Spain
12.7.5. Italy
12.7.6. Rest of Europe
12.8. Europe Transplant Diagnostic Market Attractiveness Analysis
12.8.1. By Technique
12.8.2. By Application
12.8.3. By Screening
12.8.4. By Product & Services
12.8.5. By End-user
12.8.6. By Country
13. Asia Pacific Transplant Diagnostic Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Asia Pacific Transplant Diagnostic Market Value Forecast, by Technique , 2019–2026
13.2.1. Molecular Assay
13.2.2. Non-Molecular Assay
13.3. Asia Pacific Transplant Diagnostic Market Value Forecast, by Application, 2019–2026
13.3.1. Solid Organ Transplantation
13.3.1.1. Kidney
13.3.1.2. Liver
13.3.1.3. Heart
13.3.1.4. Lungs
13.3.1.5. Pancreas
13.3.1.6. Small Bowel
13.3.2. Stem Cell Transplantation
13.4. Asia Pacific Transplant Diagnostic Market Value Forecast, by Screening, 2019–2026
13.4.1. Pre-Transplant Diagnostic
13.4.2. Post-Transplant Diagnostic
13.4.3. Instruments
13.5. Asia Pacific Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
13.5.1. Reagents & Consumables
13.5.2. Instruments
13.5.3. Software & Services
13.6. Asia Pacific Transplant Diagnostic Market Value Forecast, by End-user, 2019–2026
13.6.1. Hospital & Transplant Centers
13.6.2. Research Laboratories
13.6.3. Others
13.7. Asia Pacific Transplant Diagnostic Market Value Forecast, by Country, 2019–2026
13.7.1. China
13.7.2. Japan
13.7.3. India
13.7.4. Australia & New Zealand
13.7.5. Rest of Asia Pacific
13.8. Asia Pacific Transplant Diagnostic Market Attractiveness Analysis
13.8.1. By Technique
13.8.2. By Application
13.8.3. By Screening
13.8.4. By Product & Services
13.8.5. By End-user
13.8.6. By Country
14. Latin America Transplant Diagnostic Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Latin America Transplant Diagnostic Market Value Forecast, by Technique , 2019–2026
14.2.1. Molecular Assay
14.2.2. Non-Molecular Assay
14.3. Latin America Transplant Diagnostic Market Value Forecast, by Application, 2019–2026
14.3.1. Solid Organ Transplantation
14.3.1.1. Kidney
14.3.1.2. Liver
14.3.1.3. Heart
14.3.1.4. Lungs
14.3.1.5. Pancreas
14.3.1.6. Small Bowel
14.3.2. Stem Cell Transplantation
14.4. Latin America Transplant Diagnostic Market Value Forecast, by Screening, 2019–2026
14.4.1. Pre-Transplant Diagnostic
14.4.2. Post-Transplant Diagnostic
14.4.3. Instruments
14.5. Latin America Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
14.5.1. Reagents & Consumables
14.5.2. Instruments
14.5.3. Software & Services
14.6. Latin America Transplant Diagnostic Market Value Forecast, by End-user, 2019–2026
14.6.1. Hospital & Transplant Centers
14.6.2. Research Laboratories
14.6.3. Others
14.7. Latin America Transplant Diagnostic Market Value Forecast, by Country, 2019–2026
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Transplant Diagnostic Market Attractiveness Analysis
14.8.1. By Technique
14.8.2. By Application
14.8.3. By Screening
14.8.4. By Product & Services
14.8.5. By End-user
14.8.6. By Country
15. Middle East & Africa Transplant Diagnostic Market Analysis and Forecast
15.1.Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Technique , 2019–2026
15.2.1. Molecular Assay
15.2.2. Non-Molecular Assay
15.3. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Application, 2019–2026
15.3.1. Solid Organ Transplantation
15.3.1.1. Kidney
15.3.1.2. Liver
15.3.1.3. Heart
15.3.1.4. Lungs
15.3.1.5. Pancreas
15.3.1.6. Small Bowel
15.3.2. Stem Cell Transplantation
15.4. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Screening, 2019–2026
15.4.1. Pre-Transplant Diagnostic
15.4.2. Post-Transplant Diagnostic
15.4.3. Instruments
15.5. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Product & Services, 2019–2026
15.5.1. Reagents & Consumables
15.5.2. Instruments
15.5.3. Software & Services
15.6. Middle East & Africa Transplant Diagnostic Market Value Forecast, by End-user, 2019–2026
15.6.1. Hospital & Transplant Centers
15.6.2. Research Laboratories
15.6.3. Others
15.7. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Country, 2019–2026
15.7.1. GCC countries
15.7.2. South Africa
15.7.3. Israel
15.7.4. Rest of Middle East & Africa
15.8. Middle East & Africa Transplant Diagnostic Market Attractiveness Analysis
15.8.1. By Technique
15.8.2. By Application
15.8.3. By Screening
15.8.4. By Product & Services
15.8.5. By End-user
15.8.6. By Country
16. Competition Landscape
16.1.Market Player – Competition Matrix (by Tier and Size of companies)
16.2.Market Share Analysis by Company (2018)
16.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
16.3.1. Bio-Rad Laboratories, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Financial Overview
16.3.1.5. Strategic Overview
16.3.2. Qiagen N.V.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Financial Overview
16.3.2.5. Strategic Overview
16.3.3. F. Hoffmann-La Roche AG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Financial Overview
16.3.3.5. Strategic Overview
16.3.4. Thermo Fisher Scientific, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Financial Overview
16.3.4.5. Strategic Overview
16.3.5. Becton, Dickinson and Company
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Financial Overview
16.3.5.5. Strategic Overview
16.3.6. Ortho Clinical Diagnostics
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Financial Overview
16.3.6.5. Strategic Overview
16.3.7. Immucor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Financial Overview
16.3.7.5. Strategic Overview
16.3.8. Illumina, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Financial Overview
16.3.8.5. Strategic Overview
16.3.9. Siemens Healthineers (Siemens AG)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Financial Overview
16.3.9.5. Strategic Overview
16.3.10. Agilent Technologies
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Financial Overview
16.3.10.5. Strategic Overview
16.3.11. Others
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers